摘要
ATP结合盒超家族(ABC)转运蛋白组成了由48成员组成的7个亚科(从ABCA到ABCG)。除了其重要的生理和药理功能,ABC转运蛋白在因通过促使抗癌药物的外排而产生的多药耐药性(MDR)中扮演着重要的角色,特别是ABCB1, ABCG2 和ABCC成员。ABCB1转运蛋白抑制剂已有的研究为寻找抑制ABCB1和其他MDR相关性 ABC转运蛋白的新化合物提供的见解和策略。本文对该领域的研究进行了概括总结,重点突出了正在进行临床前和临床试验研究的药物试剂,包括酪氨酸激酶抑制剂、天然产物、microRNA和新的化学实体,并讨论了新型针对抑制癌症干细胞ABC转运蛋白的方法和该领域未来的前景。
关键词: ABC转运蛋白抑制剂,癌症干细胞,化疗,microRNA,多药耐药,酪氨酸激酶抑制剂。
图形摘要
Current Drug Targets
Title:ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy
Volume: 16 Issue: 12
Author(s): Haigang Cui, Anna J. Zhang, Mingwei Chen and Johnson J. Liu
Affiliation:
关键词: ABC转运蛋白抑制剂,癌症干细胞,化疗,microRNA,多药耐药,酪氨酸激酶抑制剂。
摘要: The superfamily of human ATP-binding cassette (ABC) transporters comprises seven subfamilies (ABCA to G) with 48 members. In addition to their profound physiological and pharmacological functions, ABC transporters play important roles in instigating multidrug resistance (MDR) in cancer by mediating the efflux of many anticancer drugs, particularly, ABCB1, ABCG2 and ABCC subfamily members. Previous development of ABCB1 transporter inhibitors has provided insights into seeking novel strategies in developing new classes of compound that inhibit ABCB1 and other MDRrelated ABC transporters. We herein review and evaluate current evidence in this area, with an emphasis on experimental and investigational agents that are under preclinical and clinical tests, including tyrosine kinase inhibitors, natural products, microRNAs and novel chemical entities. New strategies targeting ABC transporters in cancer stem cells and future perspectives in this field are also discussed.
Export Options
About this article
Cite this article as:
Haigang Cui, Anna J. Zhang, Mingwei Chen and Johnson J. Liu , ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy, Current Drug Targets 2015; 16 (12) . https://dx.doi.org/10.2174/1389450116666150330113506
DOI https://dx.doi.org/10.2174/1389450116666150330113506 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Functional Poly(ε-caprolactone) Based Materials: Preparation, Self-assembly and Application in Drug Delivery
Current Topics in Medicinal Chemistry Cancer Therapy By Targeting Hypoxia-Inducible Factor-1
Current Cancer Drug Targets Current Biological Therapies for Inflammatory Bowel Disease
Current Pharmaceutical Design Resveratrol in Medicinal Chemistry: A Critical Review of its Pharmacokinetics, Drug-Delivery, and Membrane Interactions
Current Medicinal Chemistry Vitamin D: Evolutionary, Physiological and Health Perspectives
Current Drug Targets Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry NKT Cells: A Regulator in Both Innate and Acquired Immunity
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents EGFR Inhibitors and Radiation in HNSCC
Current Cancer Therapy Reviews Cell Compatibility of an Eposimal Vector Mediated by the Characteristic Motifs of Matrix Attachment Regions
Current Gene Therapy When Does Food Refusal Require Professional Intervention?
Current Nutrition & Food Science Targeting the Eph-ephrin System with Protein-Protein Interaction (PPI) Inhibitors
Current Drug Targets Pharmacotherapy & Surgical Interventions Available for Obesity Management and Importance of Pancreatic Lipase Inhibitory Phytomolecules as Safer Anti-Obesity Therapeutics
Mini-Reviews in Medicinal Chemistry Comprehensive Profiling of the Low Molecular Weight Proteins and Peptides in Weak Cation Exchange Beads Human Serum Retentate
Protein & Peptide Letters Engineered Gold Nanoshells Killing Tumor Cells: New Perspectives
Current Pharmaceutical Design Inflammation, Microenvironment, and the Immune System in Cancer Progression
Current Pharmaceutical Design The Role of Celecoxib as a Potential Inhibitor in the Treatment of Inflammatory Diseases - A Review
Current Medicinal Chemistry Evaluation of Micro-RNA Levels, Apoptosis and Oxidative Stress Markers in Patients Recieving Chemotherapy
Combinatorial Chemistry & High Throughput Screening Genetic Surgery - A Right Strategy to Attack Cancer
Current Gene Therapy Inhibitors of the Sphingosine Kinase Pathway as Potential Therapeutics
Current Cancer Drug Targets The Coordinated Role of CYP450 Enzymes and P-gp in Determining Cancer Resistance to Chemotherapy
Current Drug Metabolism